Overview

Effects of 2 Weeks Treatment With Dapagliflozin in Subjects With an Impaired Glucose Homeostasis on Nocturnal Substrate Oxidation

Status:
Completed

Trial end date:
2021-06-29

Target enrollment:

Participant gender:

Summary

The purpose of this study is to investigate the effect of 2 weeks dapagliflozin treatment in individuals with a disrupted glucose homeostasis on the switch between carbohydrate and lipid oxidation during the night

Phase:

Phase 4

Details

Lead Sponsor:

Maastricht University

Collaborator:

AstraZeneca

Treatments:

Dapagliflozin